SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057523
Filing Date
2023-11-01
Accepted
2023-11-01 16:37:20
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-20230930.htm   iXBRL 10-Q 2028905
2 EX-31.1 prld-ex31_1.htm EX-31.1 18474
3 EX-31.2 prld-ex31_2.htm EX-31.2 18500
4 EX-32.1 prld-ex32_1.htm EX-32.1 10279
5 EX-32.2 prld-ex32_2.htm EX-32.2 10446
  Complete submission text file 0000950170-23-057523.txt   7611276

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20230930_lab.xml EX-101.LAB 363391
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20230930_pre.xml EX-101.PRE 271907
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20230930.xsd EX-101.SCH 41000
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prld-20230930_def.xml EX-101.DEF 168814
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prld-20230930_cal.xml EX-101.CAL 38943
52 EXTRACTED XBRL INSTANCE DOCUMENT prld-20230930_htm.xml XML 1500520
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 231368796
SIC: 2834 Pharmaceutical Preparations